EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The role of rifampicin in the treatment of chronic suppurative otitis media

Husam Majeed Hameed

Journal of Wasit for Science and Medicine · 2022

DOI: 10.31185/jwsm.10 ↗
AbstractBibliografische Angaben

Abstract

Back ground: Chronic suppurative otitis media (CSOM) has been an important cause of middle ear disease. The bacterial flora found in chronic suppurative otitis media varies considerably. A number of studies used fluroquinolon derivatives especially group II of this drug, like ciprofloxacinObjective: In this study there was a trial for evaluatation of the benefit of using oral rifampicin drug in the treatment of tubo- tympanic type of chronic suppurative otitis media in combination with ciprofloxacin.Patient and methods: In Al-Kerama general hospital/ENT department in Wassit 200 patients were selected divided in to two equal groups (A&B) but only164 patients continue in the study, 88 patients in group A & 76 patients in group B.Group B received the usual line of treatment in the form of oral ciprofloxacin& local (ciprofloxacin drops+ betamethason drops), while group A received the same drugs in addition to oral rifampicin. The dryness rate of the ears from discharge along six months & the recurrence rate after dryness & stopping treatment were studied. Also the laboratory results of the effect of rifampicin alone & in combination with ciprofloxacin on the bacterial growth in the culture media from ear discharge were studied.Results: Its found that the use of rifampicin in combination with other drugs used enhance faster dryness that, The percentage of ears that became dry in the 1st week were 88% & 65% for group A & group B respectively, (significant difference) . While the dryness within the 2nd week & the rest of 1st month were5.7% & 4.5% for the group A, and 15.8% & 14.4 % for group B ( It was not significant).While the recurrent rate & response to treatment after recurrence were 9% & 75% for group A against 22.3% & 52% for group B .(significant difference ).rifampicin was a safe drug & well tolerated by the patients.Conclusion: Systemic drugs like rifampicin when used might enhance rapid dryness, decrees recurrence of discharge &give us better response to treatment after recurrence.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →